Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ACLX | Arcellx, Inc. | Director | $116M | Feb 8, 2022 | ||
NGNE | Neurogene Inc. | Director | May 11, 2021 | |||
PTGX | Protagonist Therapeutics, Inc | Director | Jan 2, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|